Trimedoxime Therapy

Trimedoxime Therapy is a medical treatment modality that employs trimedoxime bromide as an acetylcholinesterase reactivator to counteract organophosphate poisoning, distinguishing it from other antidotal therapies through its specific oxime-mediated restoration of enzymatic function.

26

Publications

645

Citations

79

Authors

26

Institutions

Publications per year

2017–2026

0

Authors

79

  1. JŽ
    Jana Žďárová Karasová

    University of Defence, Czechia

    3 publications · 55 citations

    3

    h-index

  2. KK
    Kamil Kuča

    University of Hradec Králové, Czechia

    3 publications · 159 citations

    3

    h-index

  3. EK
    Eran Kozer

    Assaf Harofeh Medical Center, Israel

    2 publications · 61 citations

    2

    h-index

  4. MB
    Matitiahu Berkovitch

    Assaf Harofeh Medical Center, Israel

    2 publications · 61 citations

    2

    h-index

  5. VŠ
    Vendula Šepsová

    University of Defence, Czechia

    2 publications · 26 citations

    2

    h-index

1–5 of 79

Venues

  1. PubMed

    Repository · 6 publications · 120 citations

    6

    h-index

  2. Basic & Clinical Pharmacology & Toxicology

    BCPT · 4 publications · 156 citations

    4

    h-index

  3. Postgraduate Medical Journal

    2 publications · 48 citations

    2

    h-index

  4. 1

    h-index

  5. Chemico-Biological Interactions

    1 publications · 10 citations

    1

    h-index

1–5